» Articles » PMID: 32525957

A Comparative Analysis of the 2007 and 2017 Italian Chikungunya Outbreaks and Implication for Public Health Response

Overview
Date 2020 Jun 12
PMID 32525957
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Key Results: Both outbreaks started in small towns, but cases were also detected in nearby larger cities where transmission was limited to small clusters. The time spans between the first and the last symptom onsets were similar between the 2 outbreaks, and the delay from the symptom onset of the index case and the first case notified was considerable. Comparable infection and transmission rates were observed in laboratory. The basic reproductive number (R0) was estimated in the range of 1.8-6 (2007) and 1.5-2.6 (2017). Clinical characteristics were similar between outbreaks, and no acute complications were reported, though a higher frequency of ocular symptoms, myalgia, and rash was observed in 2017. Very little is known about the immune mediator profile of CHIKV-infected patients during the 2 outbreaks. Regarding public health responses, after the 2007 outbreak, the Italian Ministry of Health developed national guidelines to implement surveillance and good practices to prevent and control autochthonous transmission. However, only a few regional authorities implemented it, and the perception of outbreak risk and knowledge of clinical symptoms and transmission dynamics by general practitioners remained low.

Major Conclusions: Efforts should be devoted to developing suitable procedures for early detection of virus circulation in the population, possibly through the analysis of medical records in near real time. Increasing the awareness of CHIKV of general practitioners and public health officials through tailored education may be effective, especially in small coastal towns where the outbreak risk may be higher. A key element is also the shift of citizen awareness from considering Aedes mosquitoes not only as a nuisance problem but also as a public health one. We advocate the need of strengthening the surveillance and of promoting the active participation of the communities to prevent and contain future outbreaks.

Citing Articles

Strategic vaccination responses to Chikungunya outbreaks in Rome: Insights from a dynamic transmission model.

Sloof A, Boer M, Vondeling G, de Roo A, Jaramillo J, Postma M PLoS Negl Trop Dis. 2024; 18(12):e0012713.

PMID: 39652620 PMC: 11658691. DOI: 10.1371/journal.pntd.0012713.


An easier life to come for mosquito researchers: field-testing across Italy supports VECTRACK system for automatic counting, identification and absolute density estimation of Aedes albopictus and Culex pipiens adults.

Micocci M, Manica M, Bernardini I, Soresinetti L, Varone M, Di Lillo P Parasit Vectors. 2024; 17(1):409.

PMID: 39358773 PMC: 11448096. DOI: 10.1186/s13071-024-06479-z.


Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions.

Shaikh M, Faiyazuddin M, Khan M, Pathan S, Syed I, Gholap A Front Microbiol. 2024; 15:1413250.

PMID: 39104592 PMC: 11298817. DOI: 10.3389/fmicb.2024.1413250.


Arthropod-Borne Viruses of Human and Animal Importance: Overwintering in Temperate Regions of Europe during an Era of Climate Change.

Mansfield K, Schilling M, Sanders C, Holding M, Johnson N Microorganisms. 2024; 12(7).

PMID: 39065076 PMC: 11278640. DOI: 10.3390/microorganisms12071307.


Vaccine value profile for Chikungunya.

Flandes X, Hansen C, Palani S, Abbas K, Bennett C, Caro W Vaccine. 2024; 42(19S1):S9-S24.

PMID: 38407992 PMC: 11554007. DOI: 10.1016/j.vaccine.2023.07.069.


References
1.
Poletti P, Messeri G, Ajelli M, Vallorani R, Rizzo C, Merler S . Transmission potential of chikungunya virus and control measures: the case of Italy. PLoS One. 2011; 6(5):e18860. PMC: 3086881. DOI: 10.1371/journal.pone.0018860. View

2.
Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli A, Panning M . Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007; 370(9602):1840-6. DOI: 10.1016/S0140-6736(07)61779-6. View

3.
Scagnolari C, Caputo B, Rezza G, Antonelli G . Antiviral Activity of the Combination of Interferon and Ribavirin Against Chikungunya Virus: Are the Results Conclusive?. J Infect Dis. 2016; 215(3):492-493. DOI: 10.1093/infdis/jiw579. View

4.
Pialoux G, Gauzere B, Jaureguiberry S, Strobel M . Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007; 7(5):319-27. DOI: 10.1016/S1473-3099(07)70107-X. View

5.
Tsetsarkin K, Vanlandingham D, McGee C, Higgs S . A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007; 3(12):e201. PMC: 2134949. DOI: 10.1371/journal.ppat.0030201. View